Related Experiment Video
Updated: Jul 13, 2025

Concomitant Isolation of Primary Astrocytes and Microglia for Protozoa Parasite Infection
Published on: March 18, 2020
Voriconazole-induced psychosis in rhino-orbital invasive aspergillosis
H Swarna Rekha1,2, Sabharisan Paramasivam3, Kalaiarasi Raja3
1Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Abstract:
Aspergillosis is a challenging fungal infection. Voriconazole is an antifungal drug belonging to the triazole group, commonly used for treating invasive aspergillosis, Cryptococcus neoformans and candida infections. We present a case of a man in his late 70s diagnosed with rhino-orbital invasive aspergillosis who developed voriconazole-induced psychosis as an idiosyncratic, adverse drug reaction (ADR); however, he responded to the cessation of intravenous voriconazole and, after starting on an oral antipsychotic, haloperidol. Clinicians need to be cognizant of this rare, idiosyncratic and iatrogenic ADR to voriconazole.
Insights
Voriconazole, an antifungal drug, can cause rare psychosis as an adverse drug reaction (ADR). This case highlights the importance of recognizing and managing this iatrogenic effect in patients with invasive aspergillosis.
Area of Science:
- Mycology
- Pharmacology
- Neurology
Background:
- Invasive aspergillosis presents a significant clinical challenge.
- Voriconazole is a first-line triazole antifungal agent for invasive aspergillosis, Cryptococcus neoformans, and Candida infections.
- Adverse drug reactions (ADRs) to voriconazole, though uncommon, require clinical awareness.
More Related Videos
12:29Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Positive Symptoms Schizophrenia: Hallucinations and Delusions
Hallucinations
Hallucinations in...
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Typical and Atypical Agents